Skip to main content
The FDA has approved the combination of isosorbide dinitrate and hydralazine for the treatment of heart failure in the black (African decent) population.

Pharmacology Update: Isosorbide Dinitrate and Hydralazine HCL Tablets (BiDilTM)

August 15, 2005

The FDA has approved the combination of isosorbide dinitrate and hydralazine for the treatment of heart failure in the black (African decent) population.